ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
Health-Related Quality of Life in Well-treated People With HIV and Comparators Over an 8-year Period: A Longitudinal Analysis From the Prospective AGEhIV Cohort Study.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
backgroundPeople with human immunodeficiency virus (HIV) experience more comorbidities, which can reduce health-related quality of life (HRQoL). We compared HRQoL and depressive symptoms over 8 years in people with and without HIV in the AGEhIV study.
methodsWe assessed HRQoL biennially from 2010 to 2020 using 36-item Short Form Survey (SF-36) Physical and Mental Component Scores (PCS and MCS) and measured depressive symptoms with the Center for Epidemiologic Studies Depression Scale (CES-D). Participants with ≥1 SF-36 were included; people with HIV not on antiretroviral therapy (ART) or with HIV-1 ribonucleic acid (RNA) > 200 copies/mL at inclusion were excluded. Mean PCS and MCS were compared between groups using mixed-effects linear regression adjusted for sociodemographics, lifestyle, and comorbidity count, with an HIV status × visit interaction. Clinically relevant depressive symptoms (CES-D ≥ 16) were analyzed using mixed-effects logistic regression.
resultsWe included 522 people with HIV and 532 comparators, predominantly Dutch men who have sex with men, median ages of 52.9 and 52.1 years, respectively. Over a median 8.0-year follow-up, mean PCS and MCS scores were lower in people with HIV by -1.69 (95% CI, -2.28 to -1.10) and -1.25 (95% CI, -1.97 to -0.53). Clinically relevant depressive symptoms were more frequent in people with HIV (adjusted odds ratio: 2.74; 95% CI, 1.40-5.37). Changes in all endpoints over time did not differ between groups.
conclusionsWell-treated, middle-aged people with HIV may retain HRQoL comparable to individuals without HIV, with differences that, although statistically significant, might be of unclear clinical relevance due to small effect sizes. Changes in HRQoL and depressive symptoms over time do not differ between groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.